ADIPOQ and obesity disorder: Adiponectin and its signaling through the receptors AdipoR1 and AdipoR2 rank highly in the ongoing search for the holy grail that might improve insulin sensitivity, modulating inflammatory responses, and regulating energy metabolism in patients with obesity and/or Type 2 Diabetes (T2D).